It was also investigated whether nuclear factor (erythroid 2)-like factor 3 (NFE2L3) is a novel target gene of miR-1246 in human breast cancer cells, and whether its overexpression or silence could affect Doc resistance, cell migration and invasion of breast cancer cells, and the role of miR-1246. This evidence concerns the gene NFE2L3 and breast cancer.